Cowen gave the company a rating of Outperform while JP Morgan assigned its shares a Neutral rating.
The French startup plans to offer a precommercial version of its hardware platform to beta testers as early as the end of 2019.
Eurofins will distribute Synthego's sgRNA products to its customers in 44 countries.
The firm said it will use the financing to continue marketing its Engineered Cells and CRISPRevolution product lines and to expand in Europe and Asia.
The firm hasn't yet specified how many shares it is offering or at what price but noted that its stock would trade under the Nasdaq symbol TWST.
Ranomics said it has inked a distribution agreement with Axil Scientific for Ranomics' VariantFind DNA libraries in Singapore.
Arbor will provide reagents to Tataa for its courses on next-generation sequencing applications, while Tataa will distribute Arbor's products in European countries.
Researchers from Synlogic are testing a synthetic biology-based treatment for phenylketonuria, according to the New York Times.
The Intelligence Advanced Research Projects Activity has amassed a team to spot DNA orders that could be used in bioweapons, Bloomberg reports.
A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.
At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.
The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.
Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.
In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.